Glaxosmithkline Pharmaceuticals Ltd sees -4.0% decline in stock price, underperforms sector

Nov 04 2024 12:50 PM IST
share
Share Via
On November 4th, 2024, Glaxosmithkline Pharmaceuticals Ltd, a leading pharmaceutical company, saw a -4.0% decline in stock price, rated as 'Hold' by MarketsMojo. The stock underperformed the sector by -2.64% and fell after three days of gains. Moving averages are still higher than 200 day average, but lower than 5, 20, 50, and 100 day averages. Compared to Sensex, 1 day and 1 month performance was -3.80% and -4.37% respectively. Investors may want to wait for a positive trend before making any decisions.

Glaxosmithkline Pharmaceuticals Ltd, a leading pharmaceutical company in the largecap industry, saw a decline of -4.0% on November 4th, 2024. This drop in stock price was reflected in the stock call given by MarketsMOJO, which rated the stock as 'Hold'.

The stock's performance today was underwhelming, as it underperformed the sector by -2.64%. This trend reversal was evident as the stock fell after three consecutive days of gains. The day's low for the stock was Rs 2614.35, a decrease of -4% from the previous day's closing price.

Despite the recent decline, Glaxosmithkline Pharmaceuticals Ltd's moving averages are still higher than its 200 day moving average. However, it is currently lower than its 5 day, 20 day, 50 day, and 100 day moving averages.

In comparison to the Sensex, Glaxosmithkline Pharmaceuticals Ltd's 1 day performance was -3.80%, while the Sensex's performance was -1.61%. Similarly, the stock's 1 month performance was -4.37%, while the Sensex's performance was -3.98%.

Overall, Glaxosmithkline Pharmaceuticals Ltd's recent performance has been lackluster, with a decline in stock price and underperformance in the sector. Investors may want to hold off on making any decisions regarding this stock until there is a more positive trend in its performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read